DRASHTI THUMMER: Open Payments
NPI 1982294864 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 19 payments from 10 companies in 2025. Trend: 2023 $25 · 2024 $141 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $80 |
| Novo Nordisk Inc | 3 | $63 |
| PFIZER INC. | 3 | $60 |
| Amgen Inc. | 3 | $49 |
| Boston Scientific Corporation | 1 | $44 |
| Esperion Therapeutics, Inc. | 1 | $29 |
| Abbott Laboratories | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: UBRELVY, Ozempic, AMS 700, KRYSTEXXA, NEXLETOL, FREESTYLE LIBRE 3, PAXLOVID, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
